素-四元基托桑复合物诱导了卵白和黄的软组合,以缓解性结肠炎
Yajuan Li1, Jingbo Liu1, Xiaoxia Shi1
1Jilin Provincial Key Laboratory of Nutrition and Functional Food, College of Food Science and Engineering, Jilin University, Changchun 130062, People's Republic of China.
两种软组装系统,黄素-蛋白聚合物和纳米颗粒,被开发用于治疗性结肠炎. 纳米粒子通过调节肠道细菌和增强肠道屏障功能,显示出卓越的稳定性和治疗效果.
科学领域:
- 生物材料科学 生物材料科学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 和素 (Cur) 的软组合利用非共价相互作用进行功能整合.
- 开发稳定的输送系统对于治疗慢性疾病 (如性结肠炎) 的疗效至关重要.
研究的目的:
- 为了比较研究黄素-蛋白聚合物 (Cur-EWP AGs) 和黄素-蛋白-素-四分位基托桑纳米颗粒 (Cur-EWP-CA-QC NPs) 对小鼠性结肠炎的治疗效果.
- 阐明这些软组件系统在调节肠道炎症和屏障功能方面的潜在机制.
主要方法:
- 开发两个不同的软组装系统:Cur-EWP AG和Cur-EWP-CA-QC NP.
- 在体内给这些系统给性结肠炎的小鼠模型.
- 评估治疗疗效,肠道屏障完整性,免疫反应和肠道微生物群调节.
主要成果:
- 库尔-EWP AGs显示出粘液相关和短链脂肪酸 (SCAF) 生产细菌的快速结肠直肠积累和丰富,尽管胃肠道不稳定,但恢复了肠道屏障损伤.
- 库尔-EWP-CA-QCNP显示出增强的稳定性和粘膜吸附性,改善了Cur和EWP在小肠中的透性,以激活免疫反应并促进紧结蛋白表达.
- 未被吸收的Cur-EWP-CA-QCNP调节了肠道菌群,并产生了强大的抗炎活性.
结论:
- 和疏水性营养品的柔软组合可以为慢性疾病调节提供协同作用的生物活动.
- 目前的Cur-EWP-CA-QCNP提供了一个有前途的稳定交付策略,用于改善性结肠炎的治疗结果.
- 这两种系统都突出了基于的软组装在开发功能性营养药物输送系统方面的潜力.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
06:39Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
